Medication evidence profile
Influenza Virus Vaccine
Clinical overview
Influenza Virus Vaccine has public medication-list entries in GABS 2018 and KABS 2020 open validation supplement. These are 2 separate source versions, each with its own evidence and definitions.
Source-specific scores
| Source | Score |
|---|---|
| JARS | Not listed |
| Yamada-ABS | Not listed |
| BAAS | Not listed |
| Swe-ABS | Not listed |
| GABS | 0 |
| KABS | 0 |
| CALS | Not listed |
How to read this: 0 means the source explicitly assigned zero. “Not listed” means the source did not provide a score for this medication. Scores from different scales are not averaged.
How to interpret the evidence
2 of 7 public source versions contain an explicit medication-list entry for influenza virus vaccine.
The available rows for influenza virus vaccine display the same numeric value. Agreement of the displayed numbers does not establish identical methods, clinical meaning or patient-level risk.
GABS 2018 and KABS 2020 open validation supplement explicitly record zero. Those recorded zeros remain different from a missing entry.
Source labels and provenance · 2 observations
- German Anticholinergic Burden Score 2018
Source label: Influenza Virus Vaccine. Published value: 0.
Source version: GABS-2018
Source location: 12877_2018_929_MOESM1_ESM.docx Table S3 row 172
Observation: GABS_2018_R0322; rating state: published_zero. - KABS 2019 scale - 2020 open validation supplement
Source label: Influenza Virus Vaccine. Published value: 0.
Source version: KABS-2020-validation-supplement
Source location: Additional file 1; category Miscellaneous; table row 97
Observation: KABS2020_SUPP_0477; rating state: published_zero.
What this page does not establish
- No medication-list entry is available here from JARS 2025, Yamada-ABS 2023, BAAS 2019, Swe-ABS 2023, and CALS 2022 Table 4. These gaps remain “Not listed”; no score is inferred from another source or from class membership.
- No route inference unless present in the source label.
- These source records do not estimate an individual’s probability of harm or establish whether to start, stop or change a medication. Ordinal source scores are not averaged into a UnifiedACB score.
References
- Kiesel EK, Hopf YM, Drey M. An anticholinergic burden score for German prescribers: score development. BMC Geriatr. 2018;18(1):239. doi:10.1186/s12877-018-0929-6. Open source
- Suh Y, Ah YM, Han E, et al. Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale. BMC Geriatr. 2020;20(1):265. doi:10.1186/s12877-020-01671-z. Open source
Ask a follow-up
Go to your medication comparison · How UnifiedACB handles disagreement
Ask about this medication
Medication context: Influenza Virus Vaccine
Ask about this medication